glutathione synthetase deficiency Glutathione Synthetase Deficiency as a

This stabilization is crucial for patients managing the unpredictable flares associated with MCAS

Formulated in accordance with the EU Cosmetics Regulation (EC No 1223/2009) with a focus on safety, ethics & the environment

Intravenous Glutathione IV glutathione carries additional risks beyond oral supplementation [60]: Skin rashes Abdominal pain Thyroid dysfunction Liver dysfunction Kidney dysfunction and possible kidney failure Stevens-Johnson syndrome (rare) These risks have been documented particularly in the context of IV glutathione used for cosmetic skin lightening, where it may be administered repeatedly at high doses (600-2,400 mg per session) [60]

TP73 increases by 938%, while USP29 (which stabilizes p53) increases by 1,056%